Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial
Arthritis & rheumatology (Hoboken, N.J.), 2019-07, Vol.71 (7), p.1174 [Peer Reviewed Journal]2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. ;EISSN: 2326-5205 ;DOI: 10.1002/art.40874 ;PMID: 30816640
Digital Resources/Online E-Resources